Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies 2020-01-07 22:00
genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models 2020-01-07 09:00
InxMed Announces Clinical Collaboration with MSD to Evaluate IN10018 in Combination with Pembrolizumab 2020-01-07 08:25
Japanese Clinical Study of DiscGenics' Cell Therapy for Disc Degeneration Passes Initial Safety Review 2020-01-07 08:00
Inovio Provides Update on Clinical Program Plans for 2020 2020-01-06 21:00
BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma 2020-01-06 20:00
Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer 2020-01-06 20:00
Abcam Announces Successful Acquisition of Expedeon's Proteomics and Immunology Business, Enhancing Its Conjugation Capability 2020-01-06 15:00
GPHL's international headquarters settle in Macao, first project during the fifth-term government of Macao SAR 2020-01-06 14:39
Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment 2020-01-06 09:00
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency 2020-01-03 23:30
WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392 2020-01-02 08:08
CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs 2020-01-02 08:00
Oncologie Selected as Top 100 Innovative Pharmaceutical Company in China 2019-12-27 21:00
New Major Order From China 2019-12-27 19:37
Bridge Biotherapeutics Announces China NMPA Clearance of IND for BBT-401, a Pellino-1 Inhibitor for UC 2019-12-27 06:30
Viva Biotech Awarded 'Top 10 Public Companies' 2019-12-24 18:18
TOWA PHARMACEUTICAL CO., LTD. reaches an agreement with ESTEVE to acquire ESTEVE's generic division, Pensa Investments 2019-12-23 17:17
NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study 2019-12-23 08:33
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-176, an EGFR TKI for NSCLC 2019-12-20 10:19
1 316 317 318 319 320 420